The provision of a vaccine to protect against meningococcal disease caused by Neisseria meningitidis groups A, C, W and Y, to be used as part of the national childhood immunisation programme. The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to 7.4 million doses of vaccine. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
- Procurement
- MenACWY Vaccine
- Published
- 9 Feb 2022
- Status
- active
- CPV
- 33651600 — Vaccines
- Tender period
- — – 18 Mar 2022
Other notices in this procurement
This is the only notice on record.
FAQs about this notice
What type of notice is this?
This is a tender notice published via Contracts Finder on 9 Feb 2022.
Which procurement does this notice belong to?
It is part of "MenACWY Vaccine", published by Secretary of State for Health and Social Care acting as part of the Crown through the UK Health Security Agency.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable